NCT06321640 Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. Status RECRUITING Phase N/A
NCT06318871 Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT06310759 Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer Status RECRUITING Phase N/A
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06285097 A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06265285 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program Status RECRUITING Phase PHASE2
NCT06262516 Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma Status RECRUITING Phase NA
NCT06221774 Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06218433 Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) Status RECRUITING Phase NA
NCT06193941 Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits Status COMPLETED Phase N/A
NCT06178601 A Study of RC48-ADC Combined With Cadonilimab(AK104)in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma Status RECRUITING Phase PHASE2
NCT06138561 Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments Status RECRUITING Phase N/A
NCT06120374 Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC Status RECRUITING Phase N/A
NCT06111235 A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06101290 Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) Status RECRUITING Phase NA